4-{5-[3-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl}-1-{[3-(trifluoromethyl)phenyl]methyl}piperidine

Catalog No. :
ACUCNV664
CAS No. :
1025724-60-0
Molecular Formula :
C23H21F6N3
Molecular Weight :
453.43

IUPAC Name:1-(3-(trifluoromethyl)benzyl)-4-(3-(3-(trifluoromethyl)phenyl)-1H-pyrazol-5-yl)piperidine

4-{5-[3-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl}-1-{[3-(trifluoromethyl)phenyl]methyl}piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$285.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-{5-[3-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl}-1-{[3-(trifluoromethyl)phenyl]methyl}piperidine
IUPAC Name1-(3-(trifluoromethyl)benzyl)-4-(3-(3-(trifluoromethyl)phenyl)-1H-pyrazol-5-yl)piperidine
Molecular FormulaC23H21F6N3
Molecular Weight453.43
SMILESFC(C1=CC(CN2CCC(C3=NNC(C4=CC=CC(C(F)(F)F)=C4)=C3)CC2)=CC=C1)(F)F
InChI KeyOKWFAIAJKRBMPT-UHFFFAOYSA-N
Synonym1-[3-(TRIFLUOROMETHYL)BENZYL]-4-(5-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOL-3-YL)PIPERIDINE;4-{5-[3-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl}-1-{[3-(trifluoromethyl)phenyl]methyl}piperidine;Piperidine, 1-[[3-(trifluoromethyl)phenyl]methyl]-4-[5-[3-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-
CAS No.1025724-60-0

Synthetic Route by SureRoute

1. ACUCNV664 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRHNA746 route compound structure diagram
    ACRHNA746454-89-7 In Stock
  4. Then
  5. ACUCNV664 route product structure diagram
    ACUCNV6641025724-60-0
Inquiry

2. ACUCNV664 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUCNV664 route product structure diagram
    ACUCNV6641025724-60-0
Inquiry

Comments (0)